349
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen

, PhD, , BA, , PhD, ABPP, , ScD, , MD, MPH, , MD & , MD, MS show all
Pages 173-176 | Received 22 Aug 2014, Accepted 02 Jan 2015, Published online: 20 Feb 2015

References

  • Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Knowles JA, Bierut LJ, Pato MT. Comorbidity of severe psychotic disorders with measures of substance use. JAMA 2014;71:248–254
  • Kessler RC. The epidemiology of dual diagnosis. Biolog Psychiatry 2004;56:730–737
  • Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008;21:14–18
  • Large M, Sharma S, Compton M, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch General Psychiatry 2011;68:555–561
  • Stefanis N, Dragovic M, Power B, Jablensky A, Castle D, Morgan VA. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort. Schizophrenia Res 2014;156:211–216
  • Schulte S, Meier P, Stirling J, Berry M. Unrecognised dual diagnosis – a risk factor for dropout of addiction treatment. Mental Health Subst Use: Dual Diagnosis 2010;3:94–109
  • Skinner H. The Drug Abuse Screening Test. Addictive Behav 1982;7:363–371
  • Cocco KM, Carey KB. Psychometric properties of the drug abuse screening test in psychiatric outpatients. Psycholog Assess 1998;10:408–414
  • Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and DAST-1 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psycholog Assess 2000;12:186–192
  • Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Internal Med 2010;12:1155–1160
  • Bock JO, Luppa M, Brettschneider C, Riedel-Heller S, Bickel H, Fuchs A, Gensichen J, et al. Impact of Depression on Health Care Utilization and Costs among Multimorbid Patients – Results from the MultiCare Cohort Study. PLoS ONE 2014;9(3):e91973. doi:10.1371/journal.pone.0091973
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002
  • Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat 2007;32:189–198
  • Hosseini SH, Zarghami M, Mousavi SE, Nateghi GHR, Masuod Zadeh A. Study on the simultaneity of the substance abuse with psychiatric disorder in referred of psychiatry clinic of Zare hospital for period of one year. J Mazandaran Univ Med Sci 2008;18:67–74
  • Sepehrmanesh Z, Ahmadvand A, Moraveji A. Comorbidity and pattern of substance use in hospitalized psychiatric patients. Iran Red Crescent Med J 2014;16:e19282
  • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29–36
  • Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction 2013;108:1259–1269

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.